[Pflienews] PharmFacts E-News Update: Stem Cell transplants from patient's own cells yields diabetes breakthrough; more....
PFLI PharmAid Center
pfli at pfli.org
Tue Apr 14 15:35:32 MDT 2009
*PharmFacts E-News Update -- 14 Apr 2009 AD
*Media Advisory: To contact Richard K. Burt, M.D., call Marla Paul at
312-503-8928 or email marla-paul at northwestern.edu
<mailto:marla-paul at northwestern.edu>.
All done without killing innocent, involuntary embryo donors...
*Stem Cell Transplantation Helps Patients With Type 1 Diabetes Achieve
Long-Term Insulin Independence, Improves Beta-Cell Function *
WASHINGTON, D.C. -- The majority of patients with type 1 diabetes who
underwent a certain type of stem cell transplantation became insulin
free, several for more than three years, with good glycemic control, and
also increased C-peptide levels, an indirect measure of beta-cell
function, according to a study in the April 15 issue of /JAMA/, a theme
issue on diabetes.
Richard K. Burt, M.D., of the Northwestern University Feinberg School of
Medicine, Chicago, presented the findings of the study at a /JAMA/ media
briefing at the National Press Club in Washington, D.C.
Clinical evidence indicates that there is an inverse association between
beta-cell (a type of cell in the pancreas that secretes insulin)
preservation and function and chronic complications of type 1 diabetes
mellitus (DM), and the higher the C-peptide levels (a byproduct of
insulin production, made up of amino acids), the lower the incidence of
some types of complications of type 1 DM. A previous study found that
autologous nonmyeloablative hematopoietic stem cell transplantation
(HSCT) in 15 patients with newly diagnosed type 1 DM resulted in the
majority of patients becoming insulin free during the follow-up, which
averaged about 19 months. "However, it was suggested that subsequent
insulin independence was a prolonged honeymoon period due to dietary and
exercise changes associated with close posttransplant medical
observation," the authors write, and it was not known if this change was
because of an improvement in beta-cell preservation.
HSCT, which uses a patient's own blood stem cells, involves the removal
and treatment of the stem cells, and their return to the patient by
intravenous injection.
Dr. Burt and colleagues conducted a study to determine if posttransplant
insulin independence was due to improved beta-cell function by
monitoring the C-peptide levels of 23 patients who underwent stem cell
transplantation. The patients, with type 1 DM, were ages 13-31 years.
Of the 23 patients, 20 experienced time free from insulin (12
continuously and 8 transiently). Patients remained continuously insulin
free for an average time of 31 months (range, 14-52 months). One patient
had more than 4 years with no exogenous (produced outside the body)
insulin use, 4 patients for at least 3 years, 3 patients for at least 2
years, and 4 patients for at least 1 year. Eight patients relapsed and
resumed insulin use at low doses. The majority of patients achieved good
glycemic control.
In the continuously insulin-free group, average area under the curve
(AUC; a type of measurement) of C-peptide levels before transplantation
(225.0 ng/mL per 2 hours) showed a significant increase at 24 months
after transplantation (785.4 ng/mL per 2 hours) and at 36 months after
transplantation (728.1 ng/mL per 2 hours). In the transient
insulin--independent group, average AUC of C-peptide levels also
increased from 148.9 ng/mL per 2 hours pretransplantation to 546.8 ng/mL
per 2 hours at 36 months, which was sustained at 48 months. In this
group, 2 patients regained insulin independence after treatment with the
antihyperglycemic drug sitagliptin, which was associated with an
increase in C-peptide levels.
Two patients developed pneumonia in the hospital, 3 patients developed
late endocrine dysfunction, and 9 patients developed oligospermia (sperm
deficiency). There were no deaths.
"In conclusion, autologous nonmyeloablative HSCT was able to induce
prolonged and significant increases of C-peptide levels associated with
absence of or reduction of daily insulin doses in a small group of
patients with type 1 DM," the researchers write. "At the present time,
autologous nonmyeloablative HSCT remains the only treatment capable of
reversing type 1 DM in humans. Randomized controlled trials and further
biological studies are necessary to confirm the role of this treatment
in changing the natural history of type 1 DM."
(/JAMA/. 2009;301[15]:1573-1579. Available pre-embargo to the media at
www.jamamedia.org)
------------------------------------------------------------------------
*
Told ya so Dept: Oral contraceptives might raise lupus risk, study says
<http://r.smartbrief.com/resp/pqjIolmtfihdliCibTgdCicNDKZE?format=standard>
*Canadian researchers found in an eight-year study that
second-generation birth control pills made women 1.5 to 2.5 times more
prone to the autoimmune disease lupus. They also learned that the risk
of lupus was significantly lower in patients taking newer oral
contraceptives with less estrogen. HealthDay News
<http://r.smartbrief.com/resp/pqjIolmtfihdliCibTgdCicNDKZE?format=standard>
(4/9)
------------------------------------------------------------------------
*http://www.lifeissues.net/writers/irv/irv_139conscienceclause.html*
Dianne N. Irving, M.A., Ph.D.
copyright April 6, 2009
*Testimony to DHHS Re Rescinding Provider Conscience Clause*
*To:* The Department of Health and Human Services
(also posted online at www.Regulations.gov; comment ID 80945f22)
*From:* Dianne N. Irving, M.A., Ph.D., scientist and medical ethicist
5108 Randall Lane, Bethesda, MD 20816, 301-229-4176
*Date:* April 6, 2009
*Re:* *The Existing Provider Conscience Clause (document 0991-AB49)*
Pharmacists, hospitals, doctors and nurses should definitely not have to
do abortions against their conscience. To force them by law or
regulation to do so would force them to kill innocent living human
beings. Such a law or regulation would be /de facto/ a grossly unjust
law that should not be tolerated by any civilized society.
Those who would force others to kill innocent human beings at the
request of others often attempt to appeal to false scientific claims,
e.g., the product of fertilization is simply a blob, a bunch of cells,
or a piece of the mother's tissues, a potential or possible human being,
a "pre-embryo", etc. However, such claims are absurd, have no basis in
scientific fact and surely no viable or just law should be based upon
them. It has been known for well over 125 years (with the voluminous
work of Wilhelm His/ /(/Anatomie menschlicher Embryonen/, 1880-1885)
that a new, living, individual, genetically unique human being (a
single-cell human organism) is formed at the beginning of the process of
fertilization. This and similar famous research was used as the basis
of the secular /Carnegie Stages of Early Human _Embryonic_ Development/,
instituted in 1942, and documented and updated since then by the
international nomenclature committee on human embryology, i.e., the
/Nomina Embryologica/ which was part of the larger /Nomina Anatomica/
(now called the /Terminologia Embryologica/ and /Terminologia
Anatomica/). The /Carnegie Stages of Early Human Embryonic Development/
cover the new developing human being through the first 8 weeks of life,
comprising 23 Stages, and are accessible online at:
http://nmhm.washingtondc.museum/collections/hdac/Select_Stage_and_Lab_Manual.htm
at the National Museum of Health and Medicine. Quoting directly from
the /Carnegie Stages/: ...continues at the link...
<http://www.lifeissues.net/writers/irv/irv_139conscienceclause.html>
------------------------------------------------------------------------
PFLI PharmAid Center
pfli at pfli.org <mailto:pfli at pfli.org>
PO Box 1281
Powell, OH 43065-1281 USA
800-227-8359
www.pfli.org
PFLI supports pharmacist rights of conscience NOT to be forced to
dispense or counsel for chemicals which violate their sincerely held
religious, moral or ethical beliefs. For more info see:
http://www.pfli.org/main.php?pfli=conscienceclausefaq
*** PFLI is the only pharmacy association which is exclusively pro-life.
It represents thousands of pharmacists and many lay supporters
in the USA, Canada and all around the globe. For membership info, key
PFLI texts, PFLI archives, late-breaking news, abridged newsletter excerpts
or general information, visit the PFLI web site at http://www.pfli.org.
Or e-mail us at mailto:pfli at pfli.org.
*** We do NOT send out SPAM. To subscribe to PharmFacts E-News, just
send an e-mail with the word
"subscribe" in the subject area or better yet, just enroll right from
our main news page at
http://www.pfli.org; to cease your subscription [although we can't
imagine anyone would!] self-manage your account at:
http://pfli.org/mailman/listinfo/pflienews_pfli.org
*** You may contact PFLI at any/all of the following: Pharmacists For
Life International,
PO Box 1281, Powell, OH 43065-1281 USA, 1-800-227-8359 [US & Canada only],
+1-740-881-5520 [voice] or +1-707-667-2447 [fax]; e-mail us at
mailto:pfli at pfli.org.
*** You can order our publications as well as begin/renew your
membership or donate right on our
secure website at http://www.pfli.org/shop <http://www.pfli.org>. Click
on the "PFLI Store" link on the toolbar and
follow the prompts! There you can also donate to PFLI as well as
purchase a wide range of publications.
* *
--
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://pfli.org/pipermail/pflienews_pfli.org/attachments/20090414/f4afe1f8/attachment-0001.html>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: not available
Type: image/jpeg
Size: 78028 bytes
Desc: not available
URL: <http://pfli.org/pipermail/pflienews_pfli.org/attachments/20090414/f4afe1f8/attachment-0002.jpe>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: not available
Type: image/gif
Size: 2923 bytes
Desc: not available
URL: <http://pfli.org/pipermail/pflienews_pfli.org/attachments/20090414/f4afe1f8/attachment-0001.gif>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: not available
Type: image/jpeg
Size: 110551 bytes
Desc: not available
URL: <http://pfli.org/pipermail/pflienews_pfli.org/attachments/20090414/f4afe1f8/attachment-0003.jpe>
More information about the PFLIENews
mailing list